On April 27, 2010, the Supreme Court of the United States issued its opinion in Merck & Co., Inc. v. Reynolds, No. 08-905.1 The opinion resolves a circuit split regarding the two-year statute of limitations for claims brought under Section 10(b) of the Securities Exchange Act of 1934, the antifraud provision most frequently invoked by private plaintiffs.
Please see full publication below for more information.